In the competitive field of Peptide Synthesis, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Peptide Synthesis technology and learn how to protect your intellectual property.

Patent challenges are becoming increasingly common in the Peptide Synthesis industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Peptide Synthesis industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Peptide Synthesis industry

EP3110848Methods For Treating Skin Infection By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS, INC.Nov 14, 2024HAMPTON KNOWLES LIMITED
EP3110848Methods For Treating Skin Infection By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYNov 13, 2024SECERNA LLP
EP3585402Compositions, Articles Of Manufacture And Methods Related To Dosing In Cell TherapyJUNO THERAPEUTICS, INC.Nov 12, 2024BOULT WADE TENNANT LLP
EP3515465Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALS, INC.Nov 7, 2024MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBB
EP3272764Method For Affinity ChromatographyNOVARTIS AGNov 6, 2024OETKE, CORNELIA
EP3515465Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALS, INC.Nov 6, 2024SECERNA LLP
EP3515465Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALS, INC.Nov 5, 2024BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBB
EP3134120Compositions And Methods For Treating Cytokine-Related DisordersTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAOct 23, 2024SANOFI
EP3517134Adeno-Associated Virus (Aav) Serotype 8 Sequences, Vectors Containing Same And Uses ThereforTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAOct 16, 2024STRAWMAN LIMITED
EP3791896Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of CancerTRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG- UNIVERSITÄT MAINZ GEMEINNÜTZIGE GMBHOct 10, 2024DR. STRAUS, ALEXANDER

To stay ahead in the competitive Peptide Synthesis industry, companies are constantly innovating. Here are the top patents facing oppositions in the Peptide Synthesis industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2188302Nov 1, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH, INC.11
EP2462158Jan 10, 2018Method To Improve Virus Removal In Protein PurificationGENENTECH, INC.11
EP2825558May 15, 2019Combination Therapy For The Treatment Of Ovarian CancerF. HOFFMANN-LA ROCHE AG10
EP2971040Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS, INC.10
EP3177645Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLINDIS BIOTECH GMBH10
EP3616720Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentSHIONOGI & CO., LTD10
EP2791160Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNATX, INC.10
EP2766040May 15, 2019Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF. HOFFMANN-LA ROCHE AG9
EP3322731Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL-MYERS SQUIBB COMPANY9
EP2586788Nov 29, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH, INC.9